NETRF Collaborates with ERF to Fund Nuclear Medicine NET Grant

The first NETRF/ERF Nuclear Medicine Pilot Research Grant has been awarded to Thomas Hope, MD, of the University of California at San Francisco (UCSF). NETRF is funding the grant to explore innovations in nuclear medicine focused on diagnosis and treatment. ERF—The Education and Research Foundation for Nuclear Medicine and Molecular Imaging—solicited proposals and convened the scientific review panel to select the grantee.
Dr. Tom Hope Image

Accelerate, Innovate, Collaborate, Educate

Support Our Year-End Appeal
Together, we can make groundbreaking research happen! 

This holiday season, we are asking you to make a gift to the Neuroendocrine Tumor Research Foundation to help us fulfill our promise to Accelerate, Innovate, Collaborate, Educate.

Rapid progress in neuroendocrine cancer research is being made, but there is still so much more we can do. 
Help Fund More Research
SF Skyline Image

Mark Your Calendars
Save the Date - Bay Area NET Patient Education Conference on

February 4, 2017 

The NET Research Foundation, in cooperation with Stanford University Medical Center, UCSF Helen Diller Family Comprehensive Cancer Center, and the NorCal CarciNET Community is pleased to present the Sixth Annual Bay Area Neuroendocrine Patient Education Conference. A free educational conference for patients and caregivers.

Watch for more information and registration. 

NETRF-AACR Grant Opportunity

Deadline December 13, 2016

The Neuroendocrine Tumor Research Foundation-AACR Grant represents a joint effort to promote and support innovative cancer research.

This grant is available to independent junior and senior investigators to develop new ideas and innovative approaches that have direct application and relevance to intestinal carcinoid and pancreatic neuroendocrine tumors. 

NYC Image 1
NYC Image 2

International Perspectives on NETs Featured at NYC Patient Conference

NETRF’s NYC patient educational conference, on November 10, 2016, featured international perspectives on neuroendocrine cancer research and treatment. More than 150 attendees heard from 13 speakers and learned about the newest advances in neuroendocrine cancer treatment and care. Experts from Germany and Australia joined the conference via live video conferencing to share their knowledge. 

Conference presentations included the latest information on clinical trials, immunotherapy research, PRRT, surgery options, symptom management, and integrative psychosocial health. Videos of the conference presentations will be available for online viewing in the near future. Please follow NETRF on social media and for updates on their availability.

Doctor Database   Patient Groups
Newly Diagnosed   About NETs
Facebook Twitter
Contact Us

NET Research Foundation
20 Park Plaza, Suite 478
Boston, MA 02116

(617) 948-2514 |
The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for carcinoid, pancreatic, and related neuroendocrine cancers.

NETRF is a 501(c)(3) organization. All contributions are tax-deductible to the extent allowed by law. To learn more,
view our Audited Financial Statements and IRS Form 990.
powered by emma
Subscribe to our email list.